Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. No substantive changes to the study details or page functionality are evident.SummaryDifference0.0%

- Check10 days agoChange DetectedShow glossary toggle and new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe Locations section expanded with numerous new sites across multiple countries and regions, while many existing sites were removed, altering geographic coverage of the trial.SummaryDifference3%

- Check74 days agoChange DetectedPublications section updated to clarify PubMed auto-fill and the revision tag updated to v3.3.2.SummaryDifference0.0%

- Check81 days agoChange DetectedThe government funding status notice at the top of the page has been removed. It previously stated that the NIH Clinical Center is open and provided links to operating status updates.SummaryDifference0.1%

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.